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Communications about fibrinolysis activation in allergic diseases go back 
a long way. Reactions antigen-antibody induce an intravascular coagulation 
followed by fibrinolysis in c l in ica l and experimental conditions ( 1 , 11). There 
is even a parallelism between the degree of this proteolysis and the severity of 
the allergic reactions. One observes plasminogen/plasmin system act ivat ion ac-
companied by consumption of coagulation factors and F D P entrance into the 
circulat ion in an experimental model of anaphylactic shock (6, 7) . On the basis 
of these results certain authors use inhibitors of fibrinolysis in the treatment of 
allergic diseases (3). There are reports about changes of the f ibrinolyt ic blood 
ac t iv i ty in such conditions. However, observations on F D P level are rather scanty 
in these diseases. That is why we decided to study the values of these products 
together wi th the level of soluble fibrin monomeric complexes (FMC) and of the 
f ibrinolytic ac t iv i ty of the blood in various allergic diseases. 
Mater ia l and methods 
Our investigation covered 38 patients wi th allergic diseases. Patients wi th 
drug-induced allergy and different sk in manifestations such as: allergic derma-
t i t i s , erythema exudativum multiforme, urt icaria , Quincke's oedema, serum 
disease, allergic shock, predominated wi th in the contingent examined. Broad-
spectrum antibiotics prevailed amids drugs. There were a few cases of allergy 
Caused by analgin, bromates, and iodine contrast media. Investigations of patients 
were performed at the onset immediately after hospitalization before admini-
stration of corticosteroid therapy. 
F D P were quantitatively determined in the serum by using of Merskey's 
et a l . (1966) immunological method, F M C — after L i p i n s k i et a l . (1968) and fib-
r inolyt ic ac t iv i ty ( F A ) by means of euglobulinolysis (2). 
Results and discussion 
Our data obtained were demonstrated on table 1. I t could be seen that mean 
F D P and F M C levels increased stat is t ical ly significantly while F A did not change. 
These indices were examined once more in a l l the patients after disappearing 
of the allergic manifestations. The time lag between primary and secondary exa-
minations varied in accordance wi th the nature of the disease. These indices re-
turned to normal. The rest coagulogram parameters were wi th in normal ranges 
although some of them showed stat is t ical ly reliable differences in comparison 
wi th these of healthy persons. 
We observed an excessive increase of F D P up to 640 mg/1, of F M C up to 1.4 
O U , of fibrinogen up to 1.43 g/1, and thrombocytes up to 190.10^/1 in one case 
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with severe allergic shock and fatal outcome. The necropsy examination revealed 
a disseminated intravascular coagulation pattern. Th i s only case was wi th ex­
cessively high F D P levels that could sharply alter the results from the statisti­
cal processing of the data of the whole group, indeed. That is why this case was 
not included when the aforementioned data were calculated. 
The results of the correlation analysis demonstrated a strongly positive cor­
relation between F D P and F M C (coefficient 0.8376). However, the coefficients 
between F D P and fibrinogen and F D P and thrombocyte count as wel l (0.2526 
and-0.2382, respectively), were low. 
Th i s parallelism of the changes of both F D P and F M C confirmed by the cor­
relation analysis argued most probably for secondary fibrinolysis. The latter 
was of a low degree and caused a moderate dynamics of these parameters in our 
patients. The lack of fibrinolysis act ivation in the circulating blood could be ex­
plained wi th the prevalence of cases wi th relat ively slightlier expressed allergic 
manifestations excepting one patient whose characteristics was mentioned above. 
I t is most probably that the degree of fibrinolysis depends on the severity of the 
allergic manifestations as presented by the transitory F D P increase wi th these 
diseases. Our results are in accordance wi th the observations of other authors, 
too (4, 5, 10). 
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ИССЛЕДОВАНИЯ ФИБРИНОГЕНА (ФИБРИНДЕГРАДАЦИОННЫХ 
ПРОДУКТОВ) ПРИ АЛЛЕРГИЧЕСКИХ ЗАБОЛЕВАНИЯХ 
Р. Алахвердян, К- Летев 
Р Е З Ю М Е 
У 38 больных различными аллергическими заболеваниями были исследованы фибрин-
деградационные продукты, растворимые фибринмономерные комплексы и фибринолитиче-
ская активность крови. Результаты этих исследований устанавливаются наряду с обычными 
показателями коагулограммы. В ходе заболевания наблюдается умеренное повышение фиб-
риндеградационных продуктов до 14,750 мг/л. Только у одного больного с тяжелым аллер­
гическим шоком этот показатель достиг до 640 мг/л, но у него прижизненно была установле­
на консумативная коагулопатия, а при вскрытии трупа — дисеминированное свертывание 
крови внутри сосудов. При аллергических заболеваниях увеличение фибриндеградационных 
продуктов непрочное. При прекращении проявлений аллергического процесса уровень 
этих продуктов быстро доходит до нормального уровня. 
В работе обсуждаются причины появления фибриндеградационных продуктов при 
аллергических заболеваниях. j 
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